Canopy Growth

CGC

Market cap $456M

Zacks.com users have recently been watching Canopy Growth (CGC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, is pleased to announce today the voting results from its Annual General and Special Meeting of Shareholders convened on September 26, 2025 and adjourned to, and reconvened on, October 10, 2025 (the “Meeting”). All of the matters put forward before the Company's shareholders.

The Canadian cannabis sector continues to attract investors as North American legalization momentum gains strength. Recently, U.S. regulators advanced discussions on cannabis rescheduling, signaling a potential shift toward federal reform. This news lifted optimism across the industry, especially for Canadian producers eyeing future U.S. market entry. Currently, the U.S. cannabis market generates over $35 billion in annual sales and is projected to surpass $57 billion by 2030. Canadian companies are strategically positioning themselves to benefit from this growth through cross-border partnerships and product innovation. Moreover, many are expanding into wellness, beverages, and medical research to diversify revenue streams. As legalization efforts accelerate, Canadian cannabis firms could see renewed investor interest and significant upside potential in 2025.

The latest trading day saw Canopy Growth Corporation (CGC) settling at $1.37, representing a -16.97% change from its previous close.

SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, today announced that its DOJA facility in Kelowna, British Columbia is now operating exclusively as a medical cultivation site supporting the Company's Spectrum Therapeutics portfolio in Canada. The Kelowna facility will cultivate small-batch, BC-grown craft cannabis under.

DALLAS , Oct. 7, 2025 /PRNewswire/ -- JP Brand Advisors ("JPBA"), the leading outsourced sales and strategy partner for beverage alcohol and emerging functional beverage brands, and Canopy USA, LLC ("Canopy USA"), a brand-driven organization strategically positioned across the U.S. cannabis market, today announced a strategic partnership to expand the distribution of Wana Wellness, LLC ("Wana")'s hemp-based beverages and gummies in the United States. The partnership underscores JPBA's expanding focus on hemp-based functional beverages, a category generating significant attention across the beverage alcohol industry as consumer demand for wellness-driven innovation accelerates.

In case you haven't heard, President Donald Trump just gave his "strongest signal yet that movement on cannabis policy may be imminent" and that the federal government may be ready to finally legalize marijuana use in the U.S.

Cannabis stocks are in focus after President Trump said CBD could "revolutionize senior healthcare" in a Truth Social post. The comment sent bullish signals through the cannabis space, coming months after reports that the president was considering reclassifying weed.

Trump's CBD video fuels momentum in cannabis, with Village Farms, Canopy Growth, and Tilray emerging as stocks to watch in 2025.

Canopy Growth Corporation (CGC) closed the most recent trading day at $1.36, moving 1.45% from the previous trading session.